Scion Life Sciences
Venture capitalNew York · Seed–Late Stage · 6 people tracked
Investment thesis
Scion Life Sciences is a life sciences venture capital firm affiliated with Petrichor that invests in biotechnology companies developing therapeutic and curative medicines. The firm takes a long-term ownership approach to supporting companies from founding through commercialization.
Team · 6 people
from the firm's websiteFrequently asked questions
- What stage does Scion Life Sciences invest at?
- Scion Life Sciences invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Scion Life Sciences focus on?
- Scion Life Sciences focuses on Biotech, Medical Devices.
- Where is Scion Life Sciences located?
- Scion Life Sciences is headquartered in New York, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
A European investment firm established in 2016 by former Index Ventures life sciences professionals with over 20 years of experience in drug discovery and therapeutic development for unmet medical needs.